LDLR and Hepatic steatosis: In conclusion, the current study showed for the first time that GPR40 KO in LDLR-deficient mice worsened HFD-induced hepatic steatosis, inflammation and fibrosis by potentially increasing FFAs and cholesterol and upregulating hepatic CD36 expression.